QDEL QuidelOrtho Corporation
$13.59▼ -1.31%
Healthcare
Other
After hours
$13.59▲ +0.00%
Oct 27, 4:47 PM ET
Volume 2.08M
Avg Volume (10D) 2.16M
Key Metrics & Fundamentals
Market Cap
$931.94M
P/E Ratio
–
Div Yield
0.00%
52W Range
9.92 - 35.58
% vs 50 MA
6.35%
% vs 200 MA
-17.93%
RSI-14
55.4
MACD Histogram
+0.1000
Beta (1Y vs SPY)
2.64
Free Cash Flow
-$136.10M
Gross Rev
$630.90M
Gross Profit
$272.90M
EBITDA
$95.00M
COGS
$358.00M
Operating Exp
$288.20M
Operating Income
-$15.30M
EBIT
-$15.30M
Pretax Income
-$81.20M
Net Income
-$92.90M
EPS (Diluted)
-1.36
Price & Volume History
Loading chart…
Recent News

3 unprofitable stocks walking a fine line
StockStory · Oct 22, 2026 2:21 PM ET

QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
PR Newswire · Oct 20, 2026 8:00 AM ET

Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know
StockStory · Oct 16, 2026 4:51 PM ET

QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire · Oct 15, 2026 6:10 PM ET

Reasons to Add QuidelOrtho Stock to Your Portfolio for Now
Zacks · Oct 14, 2026 9:38 AM ET

QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · Oct 12, 2026 3:19 PM ET

QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
PR Newswire · Oct 7, 2026 7:13 AM ET

2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges
StockStory · Sep 25, 2026 11:36 AM ET

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment
PR Newswire · Sep 24, 2026 9:12 AM ET

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
StockStory · Sep 23, 2026 5:30 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See QDEL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.